Outcomes12

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 12 of 12

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Cure Rates of AQ-13 and Coartem for Uncomplicated Plasmodium Falciparum Malaria in Adult Malian Males.	Subjects are followed for 42 days after beginning treatment with either AQ-13 or Coartem..		Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Number of Participants With Adverse Events	Within 4 weeks of beginning treatment with either AQ-13 or Coartem		Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Parasite Clearance Time	From the time of beginning treatment with either AQ-13 or Coartem to the first of 2 successive negative blood smears, assessed during the 1 week inpatient stay.		Hour	MEAN
SECONDARY	Number of Participants With Recrudescence of Infection	Within 42 days after beginning treatment with either AQ-13 or Coartem	Two participants who withdrew on day 4 and three who were lost to follow-up were not included in this analysis.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	QTc Interval Response Following Antimalarial Treatment	Between dosing and 4 hours after dosing		ms	MEAN
SECONDARY	Mean Fever Clearance Time in Days	Days 1-7 after beginning treatment with either AQ-13 or Coartem		Days	MEAN
SECONDARY	Peak Cmax	42 Days		μM	MEAN
SECONDARY	Time to Peak Tmax	42 days		Hours	MEAN
SECONDARY	1-week AUC	42 days		μM/h	MEAN
SECONDARY	Mean Residence Time	42 Days		Days	MEAN
SECONDARY	Clearance	42 Days		L/h	MEAN
SECONDARY	Elimination t½	42 Days		Days	MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01614964/outcomes